| 24101/34347 | US=84 / Biol/Mol Kim SS, Shuman C, Mishra L. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: component hardware for transformig growth factor-B signal transduction: Interaction of smad4 and embryonic liver fodrin-B-spectrin in hyperplasia, neoplasia, and tumor suppression. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 91-103. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B; SMAD4; CAMUNDONGOS KNOCKOUT; TUMORIGENESE; FATOR TRANSFORMADOR DE CRESCIMENTO |
| 24102/34347 | US=84 / Biol/Mol Liu F. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: component hardware for transformig growth factor-B signal transduction: regulation of smad activity by phosphorylation. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 105-23. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B; SMAD; FOSFORILACAO; FOSFATASE; QUINASE DO RECEPTOR; MAP QUINASE; CDK; CANCER |
| 24103/34347 | US=84 / Biol/Mol Xu L. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: nuclear targeting of TGF-B-activated smads in normal and tumor biology. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 125-37. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. IMPORTACAO NUCLEAR; EXPORTACAO NUCLEAR; NUCLEO-CITOPLASMATICO; SMAD; TGF-B |
| 24104/34347 | US=84 / Biol/Mol Xu L. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: ski, snoN, and aKt as negative regulators of smad activity: balancing cell death and cell survival regulatorsnuclear targeting of TGF-B-activated smads in normal and tumor biology. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 139-53. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 24105/34347 | US=84 / Biol/Mol Zhang YE, Yamashita M. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: transforming growth factor-B in cancer therapy: smurfs in TGF-B signaling and regulation of bone homeostasis and cancer. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 155-67. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 24106/34347 | US=84 / Biol/Mol Jin Q, Gao G, Mulder KM. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: involvement of km23 dynein light chains in TGF B signaling. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 169-84. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. KM23; TGF-B; DINEINA; TRANSDUCAO DE SINAL; CANCER; FATOR DE CRESCIMENTO; PROTEINA MOTOR; DYNLRB; SMAD; TRAFICO |
| 24107/34347 | US=84 / Biol/Mol Bhowmick NA. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: TGF-B signaling in fibroblastic cells and oncogenesis. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 185-98. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B; CELULAS ESTROMAIS; MESENQUIMA; PANCA; PROSTATA; TUMORIGENESE |
| 24108/34347 | US=84 / Biol/Mol Kim TA, Kim SJ. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: mechanisms of TGF-B-induced apoptosis in cancer cells. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 199-211. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 24109/34347 | US=84 / Biol/Mol Gold LI, Lecanda J. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: mechanisms of cell cycle regulation by TGF-B disabled in cancer. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 213-42. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. P27KIP1; CKS1; SKP2; CANCRO ENDOMETRIAL; UBIQUITINA-PROTEASSOMA |
| 24110/34347 | US=84 / Biol/Mol Band A, Laiho M. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: transforming growth factor-B in cancer therapy. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 243-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-BETA; SMAD; TRANSDUCAO DE SINAL; SNON; PROTEASSOMA; UBIQUITINA; SUMO; DEGRADACAO |
| 24111/34347 | US=84 / Biol/Mol Thuault S, Valcourt U, Kowanetz M, Moustakas A. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: TGF-B and smad signaling in transcriptome reprogramming during EMT. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 259-73. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. ADERENTES JUNCAO; EMT; METASTASE; POLARIDADE; JUNCAO APERTADA |
| 24112/34347 | US=84 / Biol/Mol Stuelten CH, Roberts AB, Stetler-Stevenson WG. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: functional interactions between MMPs and TGF-B in normal and tumor tissue. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 275-92. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-B; MMP; TUMOR; INTERACAO ESTROMA TUMORAL; SINALIZACAO CELULAR |
| 24113/34347 | US=84 / Biol/Mol Liu IM, Schilling SH, Wang XF. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: Cooperation between TGF-B and Wnt pathway components in regulating mesenchymal stem cell function. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 293-303. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. CELULAS-TRONCO MESENQUIMAIS; SMAD3; B-CATENINA; CROSSTALK; PROLIFERACAO; DIFERENCIACAO |
| 24114/34347 | US=64 / Câncer Dhodapkar MV. Immunobiology and immunotherapy of multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 167-202. (Comtemporary Hematology) ISBN 978-1-934115-82-4. IMUNOLOBIOLOGIA DO MIELOMA MULTIPLO; IMUNOTERAPIA DO MIELOMA MULTIPLO |
| 24115/34347 | US=84 / Biol/Mol Glick A, Bae DS, Liu X, Vijayachandra K. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: interaction of oncogenic ras and TGFB1 signaling in cancer: lessons from the multistage skin carcinogenesis model. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 305-15. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGFB1; ONCOGENE RAS; PELE; QUERATINOCITOS; VARIOS ESTAGIOS DA CARCINOGENESE; CANCER DE PELE |
| 24116/34347 | US=84 / Biol/Mol Souchelnytskyi S. TGF-B superfamily members in normal and tumor biology: proteomics analysis of TGFB superfamily members. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 319-31. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. PROTEOMICA; SINALIZACAO; FACTOR DE CRESCIMENTO TRANSFORMANTE-B; PROTEINAS MORFOGENETICAS DO OSSO; SMAD |
| 24117/34347 | US=84 / Biol/Mol MacLaughlin DT, Donahoe PK. TGF-B superfamily members in normal and tumor biology: mullerian inhibiting substance: a potencial nontoxic, naturally occurring therapeutic agent for certain human cancers. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 333-53. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 24118/34347 | US=84 / Biol/Mol Hayashida T, Gupta V, Thiagalingam S, Maheswaran S. TGF-B superfamily members in normal and tumor biology: activins, inhibins, and bone morphogenetic proteins as modulators and biomarkers of prostate cancer progression. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 355-72. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. CANCER DE PROSTATA; ACTIVINA; PROTEINAS MORFOGENETICAS DO OSSO; INIBINAS; ALK2; ALK3; ALK6; ACTIVINA RECEPTOR TIPO II; BMP RECEPTOR TIPO II |
| 24119/34347 | US=84 / Biol/Mol Berberian G, Malhotra D, Langenfeld JE. TGF-B superfamily members in normal and tumor biology: bone morphogenic proteins and angiogenesis in developing tumors. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 373-81. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. ACTIVINA; PROTEINAS MORFOGENETICAS DO OSSO; INIBINAS; ALK2; ALK3; ALK6; ACTIVINA RECEPTOR TIPO II; BMP RECEPTOR TIPO II |
| 24120/34347 | US=84 / Biol/Mol Leader JE, Frontelo MP, Lechleider RJ. TGF-B superfamily members in normal and tumor biology: histone methyltransferase and smad interactions in BMP signaling. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 383-93. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. HISTONA METILTRANSFERASE; SMAD; BMP; RECEPTORES DE CELULAS DE SUPERFICIE; FAMILIA SUV39H; CROMATINA |